December 2025
Learning Objectives
By completing this eLearning module:
- Clinicians will gain diagnostic knowledge and greater competence for early recognition and referral for CIDP. (Moore’s levels 3 and 4)
- HCPs will gain confidence in using advanced diagnostic techniques and comprehensive testing for accurate CIDP diagnosis. (Moore’s level 4)
- Clinicians will be able to utilize their enhanced understanding of the role of the immune system and the relevant pathways underlying CIDP to effectively plan personalized treatment approaches for patients. (Moore’s level 4)
- HCPs will advance their understanding of personalized treatment strategies and emerging therapies like complement pathway inhibitors for CIDP. (Moore’s level 3)
Activity Disclosures
This activity is supported by an educational grant from Sanofi.
Disclaimer
Prof. Jeffrey Allen: Honoraria, consultation fees, advisory board from Alexion, Alnylam, Akcea therapeutics, Argenx SE, Annexon,Dianthus, CSL Behring, Hansa, Grifols, Immunovant, Immunopharm, ImmunoAbs, Sanofi, Johnson & Johnson, Pfizer, Takeda
Prof. Karissa Gable: Consultant/Advisor to Argenx, Takeda, Sanofi, CS Behring, Immunovant, Grifols, Dianthus
Prof. Richard Lewis: Consultant/Advisory Boards; Adjudication Committee: Alexion [CIDP; MMN];Amgen (CIDP); Annexon [GBS, CIDP];Argenx [CIDP]; Avilar (anti- MAG); BioCryst (CIDP) CSL Behring [CIDP]; Dianthus [CIDP, MG]; Grifols [CIDP, MMN];Immunovant (CIDP, MMN); J&J [CIDP]; Nervosave (CMT); Nuvig (CIDP); Sanofi [GBS, CIDP, MMN]; Seismic (Anti-MAG);Takeda [CIDP]. TGTX (CIDP); DSMB Boehringer Ingleheim; Intellia (TTR); Cartesian (MG)- chair; MAB: GBS-CIDP FoundationInternational; Speaker: Medscape; Royalties: Up to Date (CIDP)
This activity underwent review in line with standards of editorial integrity and publication ethics. Potential conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest. The primary resolution method was review by an unconflicted expert. For information about the accreditation of this program, please contact [email protected].
Accreditation
John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
John Wiley and Sons, Inc. designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within 1 hour and complete the activity during the valid credit period, which is up to three years from initial publication. Additionally, up to 3 attempts and a score of 70% or higher is needed to pass the post-test and claim credit. You will need to log into your Wiley Health Learning account (registration is free) to complete this activity and earn a certificate.
To begin, please click the Pre-test button below to contribute to our outcomes data then proceed to the course content.
